Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSH.L Regulatory News (CSH)

  • There is currently no data for CSH

Update research from QuotedData

19 Nov 2021 08:58

RNS Number : 9634S
Civitas Social Housing PLC
19 November 2021
 

Civitas Social Housing - Update research from QuotedData

17th November 2021

 

Short shrift to short seller

 

An unwarranted attack by an activist short seller on the fabric of Civitas Social Housing (CSH), coinciding with it falling out of the FTSE 250 index, has driven down CSH's share price in recent months. CSH has published a strong rebuttal (details of the claims and CSH's response are on page 6) saying these claims are baseless. The short seller may have made a quick profit, however CSH has had to put a planned capital raise to grow its portfolio on ice and it has impacted the wider sector to the detriment of thousands of people in need of specialist housing.

 

The fundamentals that support growth in the sector remain strong and aren't going away, namely increased demand from individuals and a lack of supply (as detailed on pages 4 and 11). The high dividend yield and the large discount to net asset value (NAV) that CSH's shares are now trading on and the increased dividend target for this year seem appealing.

 

Full research:

https://quoteddata.com/research/civitas-social-housing-short-shrift-short-seller-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

 

 NB: Marten & Co was paid to produce this note on Civitas Social Housing and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUKVWRABUAARA
Date   Source Headline
12th Aug 20225:00 pmRNSNotice of Annual General Meeting
10th Aug 20227:00 amRNSTrading and Market Update
1st Jul 20222:59 pmRNSTotal Voting Rights
30th Jun 20227:00 amRNSCivitas Full Year Results
15th Jun 20227:00 amRNSNotice of Full Year Results
27th May 20224:18 pmRNSResearch from QuotedData
17th May 20225:14 pmRNSHolding(s) in Company
16th May 20222:55 pmRNSHolding(s) in Company
11th May 20227:00 amRNSQuarterly Portfolio Update
4th May 20221:02 pmRNSTransaction in Own Shares
4th May 20221:01 pmRNSTotal Voting Rights
27th Apr 20227:00 amRNSTransaction in Own Shares
21st Apr 20227:00 amRNSTransaction in Own Shares
20th Apr 20227:00 amRNSTransaction in Own Shares
14th Apr 20227:00 amRNSTransaction in Own Shares
11th Apr 20227:00 amRNSTransaction in Own Shares
6th Apr 20224:07 pmRNSPurchase of Shares in Closed Period
16th Mar 20222:22 pmRNSReplacement: Update on Shareholder Views post AGM
16th Mar 20221:22 pmRNSHolding(s) in Company
16th Mar 20227:00 amRNSUpdate on Shareholder Views Following AGM
9th Mar 20225:30 pmRNSDirector/PDMR Shareholding
8th Mar 20223:10 pmRNSHolding(s) in Company
1st Mar 20224:23 pmRNSTotal Voting Rights
22nd Feb 20226:08 pmRNSHolding(s) in Company
16th Feb 20223:54 pmRNSHolding(s) in Company
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20226:17 pmRNSHolding(s) in Company
14th Feb 20226:12 pmRNSHolding(s) in Company
14th Feb 20227:00 amRNSInvestment Grade Credit Rating Affirmed
9th Feb 20225:00 pmRNSHolding(s) in Company
9th Feb 20227:05 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSNet Asset Value, Trading and Dividend Update
8th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20224:21 pmRNSHolding(s) in Company
24th Jan 20225:37 pmRNSHolding(s) in Company
23rd Dec 20213:29 pmRNSHolding(s) in Company
20th Dec 20214:05 pmRNSDirector/PDMR Shareholding
17th Dec 20212:48 pmRNSHolding(s) in Company
9th Dec 20215:00 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSInterim Results
6th Dec 20217:00 amRNSNotice of Interim Results
1st Dec 20214:19 pmRNSTotal Voting Rights
1st Dec 20217:00 amRNSTransaction in Own Shares
29th Nov 20217:00 amRNSTransaction in Own Shares
25th Nov 20217:00 amRNSTransaction in Own Shares
22nd Nov 20217:00 amRNSTransaction in Own Shares
19th Nov 20218:58 amRNSUpdate research from QuotedData
15th Nov 20217:00 amRNSTransaction in Own Shares
12th Nov 202110:00 amRNSResponse to Regulatory Judgement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.